Apobiologix, a division of Apotex Inc., today launched its first oncology therapeutic treatment nationally. The company, a pioneer and leader in oncology biosimilars in Canada, launched Bambevi® (bevacizumab), which is used in combination with chemotherapy to treat specific types of colorectal, lung, brain and ovarian cancer.
November 9, 2021
· 3 min read
